Given that cancer cells require EXO1 for counteracting stress due to abnormal DNA replication, small molecules targeting EXO1 represent a major opportunity for specifically killing cancer cells by targeting the aberrant replication-associated repair system in human breast cancer and other hormone-related cancers. Here, EXO1 is linked to breast cancer.